bi-and tri-specific antibodies in non-hodgkin lymphoma: current data and perspectives
Published 1 year ago • 966 plays • Length 1:16:35Download video MP4
Download video MP3
Similar videos
-
38:40
bispecific antibodies in lymphoma: an update
-
3:49
the challenges in developing bispecific antibodies for non-hodgkin lymphoma
-
1:01:08
bispecific antibodies in lymphoma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
54:11
car t-cells in lymphoma: new advances and practical aspects
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
48:12
outcomes of patients with aggressive b-cell lymphoma after failure of anti-cd19 car t-cell therapy
-
6:06
bispecific antibody treatment in non-hodgkin lymphoma: epcoritamab - blood cancers onctalk 2023
-
1:34
how will bispecifics impact the treatment of nhl?
-
1:00:51
latest advances in the management of hodgkin lymphoma
-
4:27
the possibility of combining car-t therapy and bispecific antibodies in the treatment of nhl
-
3:20
bispecific antibodies in nhl: current insights and ongoing studies
-
1:17
the promise of bispecific antibodies in the treatment of nhl
-
10:40
evolving role of bispecific antibodies in b-cell non-hodgkin lymphomas (b-nhl)
-
16:07
evolving role of bispecific antibodies in b-cell non-hodgkin lymphomas (b-nhl)
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:46
road ahead for immunotherapy in hodgkin lymphoma: bispecifics & car-t
-
46:28
bispecific antibodies in the management of non-hodgkin lymphoma with dr matthew matasar